Adial Pharmaceuticals, Inc. (ADIL) Balance Sheet
ADIL balance sheet, 2025
December 31, 2025 · U.S. dollars$6.8M assets = $1.5M liabilities + $5.3M equity
Both columns are drawn to the same scale: what ADIL owns equals what it owes plus shareholders’ equity. Hover a block for its value.
ADIL financial health
Descriptive bands, not a rating. Fiscal 2025.
ADIL balance sheet trends, 2016–2025
| Metric | Trend | Then | Latest | Change |
|---|---|---|---|---|
| Total assets | $151,5262016 | $6.8M2025 | +52.6%/yr | |
| Total liabilities | $255,0192016 | $1.5M2025 | +22.0%/yr | |
| Shareholders’ equity | −$103,4932016 | $5.3M2025 | — | |
| Cash & short-term investments | $87,9932016 | $5.9M2025 | +59.5%/yr | |
| Total debt | $234,2552016 | $207,3752022 | −2.0%/yr | |
| Net cash (debt) | −$146,2622016 | $3.8M2022 | +$3.9M | |
| Working capital | −$113,6062016 | $4.8M2025 | +$4.9M | |
| Book value per share | $5.472024 | $7.892025 | +44.2%/yr | |
| Current ratio | 0.552016 | 4.422025 | +3.87 | |
| Debt / equity | 0.072021 | 0.062022 | −0.01 | |
| Shares outstanding | 744K2024 | 669K2025 | −10.1%/yr |
Change is the average annual growth (CAGR) or the difference between the first and latest year.
ADIL assets
ADIL liabilities and equity
ADIL debt vs cash
Debt includes short- and long-term borrowings and, where reported, lease obligations.
ADIL balance sheet
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Cash & short-term investments | $5.9M | $3.8M | $2.8M | $4.0M | $6.1M | $4.4M | $6.8M | $3.9M | $18,248 | $87,993 |
| Cash & equivalents | $5.9M | $3.8M | $2.8M | $4.0M | $6.1M | $4.4M | $6.8M | $3.9M | $18,248 | $87,993 |
| Receivables | $41,758 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $35,117 |
| Inventory | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other current assets | $257,908 | $308,239 | $371,597 | $778,141 | $399,432 | $734,724 | $896,415 | $823,507 | $9,000 | $18,303 |
| Total current assets | $6.2M | $4.1M | $3.2M | $4.8M | $6.5M | $5.1M | $7.7M | $4.7M | $27,248 | $141,413 |
| Property, plant & equipment (net) | $0 | $0 | $3,909 | $244,421 | $304,358 | $0 | $0 | $0 | $0 | $0 |
| Goodwill & intangible assets | $2,784 | $3,348 | $3,913 | $253,448 | $254,012 | $5,606 | $6,170 | $6,735 | $7,298 | $7,863 |
| Long-term investments | $489,700 | $981,830 | $1.5M | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other non-current assets | $125,000 | $0 | $0 | $455,000 | $613,913 | $350,000 | $0 | $0 | $0 | $2,250 |
| Total assets | $6.8M | $5.0M | $4.7M | $5.7M | $7.6M | $5.5M | $7.7M | $4.7M | $34,546 | $151,526 |
| Liabilities | ||||||||||
| Accounts payable | $655,207 | $250,130 | $103,325 | $276,410 | $286,192 | $648,739 | $190,204 | $99,671 | $342,082 | $20,012 |
| Short-term debt | — | — | — | $56,828 | $49,585 | — | — | — | $689,265 | $234,255 |
| Deferred revenue | — | — | — | — | $2.4M | — | — | — | — | — |
| Total current liabilities | $1.4M | $975,858 | $653,076 | $1.8M | $2.7M | $1.5M | $539,051 | $257,974 | $1.0M | $255,019 |
| Long-term debt | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Lease obligations | — | — | — | $207,375 | $256,960 | $0 | — | — | — | — |
| Other long-term liabilities | $125,000 | $0 | $437 | $665,444 | $1.4M | $648,739 | $190,204 | $0 | $0 | $0 |
| Total liabilities | $1.5M | $975,858 | $653,513 | $2.5M | $4.1M | $1.5M | $539,051 | $257,974 | $1.0M | $255,019 |
| Shareholders' equity | ||||||||||
| Common stock & paid-in capital | $1,111 | $6,473 | $1,663 | $1,067 | $20,947 | $14,393 | $10,368 | $6,863 | $3,268 | $9.8M |
| Retained earnings (deficit) | −$90.0M | −$82.0M | −$68.8M | −$63.7M | −$50.9M | −$31.5M | −$20.6M | −$12.0M | −$403,992 | −$9.9M |
| Accumulated other comprehensive income | — | — | — | $0 | $0 | — | $0 | — | −$596,829 | — |
| Total shareholders' equity | $5.3M | $4.1M | $4.1M | $3.3M | $3.5M | $4.0M | $7.1M | $4.4M | −$997,553 | −$103,493 |
| Key figures | ||||||||||
| Total debt | — | — | — | $207,375 | $256,960 | — | — | — | $689,265 | $234,255 |
| Net cash (debt) | — | — | — | $3.8M | $5.8M | — | — | — | −$671,017 | −$146,262 |
| Working capital | $4.8M | $3.1M | $2.5M | $3.0M | $3.7M | $3.6M | $7.1M | $4.4M | −$1.0M | −$113,606 |
| Tangible book value | $5.3M | $4.1M | $4.1M | $3.0M | $3.3M | $4.0M | $7.1M | $4.4M | −$1.0M | −$111,356 |
| Book value per share | $7.89 | $5.47 | — | — | — | — | — | — | — | — |
| Shares outstanding | 669K | 744K | — | — | — | — | — | — | — | — |
| Current ratio | 4.42 | 4.16 | 4.90 | 2.67 | 2.37 | 3.41 | 14.24 | 18.19 | 0.03 | 0.55 |
| Quick ratio | 4.24 | 3.84 | 4.33 | 2.23 | 2.23 | 2.92 | 12.57 | 15.00 | 0.02 | 0.48 |
| Debt / equity | — | — | — | 0.06 | 0.07 | — | — | — | — | — |
| Equity / assets | 77.6% | 80.7% | 86.2% | 57.2% | 46.0% | 72.6% | 93.0% | 94.5% | −2,887.6% | −68.3% |
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 | Jun '24 | Mar '24 | Dec '23 | Sep '23 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||
| Cash & short-term investments | $28.7M | $4.6M | $5.9M | $4.6M | $5.9M | $2.4M | $3.8M | $5.2M | $3.3M | $5.0M | $2.8M | $315,880 |
| Cash & equivalents | $28.7M | $4.6M | $5.9M | $4.6M | $5.9M | $2.4M | $3.8M | $5.2M | $3.3M | $5.0M | $2.8M | $315,880 |
| Receivables | $0 | $0 | $41,758 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $350,000 |
| Inventory | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other current assets | $133,000 | $218,848 | $257,908 | $407,543 | $163,647 | $263,395 | $308,239 | $414,237 | $535,354 | $311,356 | $371,597 | $469,606 |
| Total current assets | $28.8M | $4.8M | $6.2M | $5.0M | $6.1M | $2.6M | $4.1M | $5.6M | $3.8M | $5.3M | $3.2M | $1.1M |
| Property, plant & equipment (net) | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $3,909 | $0 | $0 |
| Goodwill & intangible assets | $3,000 | $2,643 | $2,784 | $2,925 | $3,066 | $3,207 | $3,348 | $3,489 | $3,631 | $3,772 | $3,913 | $4,054 |
| Long-term investments | $241,000 | $421,730 | $489,700 | $643,090 | $720,010 | $818,740 | $981,830 | $1.1M | $1.1M | $1.3M | $1.5M | $1.7M |
| Other non-current assets | $0 | $0 | $125,000 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total assets | $29.1M | $5.2M | $6.8M | $5.7M | $6.8M | $3.5M | $5.0M | $6.7M | $4.9M | $6.7M | $4.7M | $2.9M |
| Liabilities | ||||||||||||
| Accounts payable | $2.6M | $573,567 | $655,207 | $556,284 | $671,118 | $532,430 | $250,130 | $318,118 | $316,726 | $177,468 | $103,325 | $81,925 |
| Total current liabilities | $5.1M | $1.5M | $1.4M | $1.2M | $1.2M | $1.3M | $975,858 | $829,046 | $671,882 | $562,731 | $653,076 | $528,179 |
| Long-term debt | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other long-term liabilities | $23.8M | $0 | $125,000 | $0 | $0 | $0 | $0 | $0 | $0 | $437 | $0 | $0 |
| Total liabilities | $28.9M | $1.5M | $1.5M | $1.2M | $1.2M | $1.3M | $975,858 | $829,046 | $671,882 | $562,731 | $653,076 | $528,179 |
| Shareholders' equity | ||||||||||||
| Common stock & paid-in capital | $3,000 | $1,509 | $1,111 | $23,836 | $21,535 | $6,650 | $6,473 | $6,404 | $4,292 | $4,054 | — | $1,218 |
| Retained earnings (deficit) | −$144.0M | −$92.0M | −$90.0M | −$88.0M | −$86.2M | −$84.2M | −$82.0M | −$79.9M | −$77.7M | −$75.3M | −$68.8M | −$66.9M |
| Accumulated other comprehensive income | — | — | — | — | — | — | — | — | $0 | $0 | — | — |
| Total shareholders' equity | $156,000 | $3.7M | $5.3M | $4.5M | $5.6M | $2.1M | $4.1M | $5.9M | $4.3M | $6.1M | $4.1M | $2.3M |
| Key figures | ||||||||||||
| Working capital | $23.7M | $3.3M | $4.8M | $3.9M | $4.9M | $1.3M | $3.1M | $4.8M | $3.2M | $4.8M | $2.5M | $607,307 |
| Tangible book value | $153,000 | $3.7M | $5.3M | $4.5M | $5.6M | $2.1M | $4.1M | $5.9M | $4.3M | $6.1M | $4.1M | $2.3M |
| Book value per share | $0.03 | $2.71 | $4.75 | $5.08 | — | $2.86 | $5.47 | — | — | — | $2.45 | — |
| Shares outstanding | 4.6M | 1.4M | 1.1M | 887K | — | 744K | 744K | — | — | — | 1.7M | — |
| Current ratio | 5.63 | 3.18 | 4.42 | 4.34 | 5.02 | 1.99 | 4.16 | 6.78 | 5.69 | 9.48 | 4.90 | 2.15 |
| Quick ratio | 5.61 | 3.04 | 4.24 | 3.99 | 4.88 | 1.79 | 3.84 | 6.28 | 4.89 | 8.93 | 4.33 | 1.26 |
| Equity / assets | 0.5% | 71.1% | 77.6% | 79.6% | 82.2% | 61.6% | 80.7% | 87.6% | 86.4% | 91.6% | 86.2% | 81.6% |
Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported (latest annual report filed March 5, 2026); data from EODHD.
ADIL financial position
At the end of fiscal 2025 (December 31, 2025), Adial Pharmaceuticals had total assets of $6.8 million (up 34.8% from a year earlier), total liabilities of $1.5 million and shareholders' equity of $5.3 million. Its current ratio was 4.42. In the latest quarter (ended June 30, 2026) total assets were $29.1 million and equity $0.2 million.
Related: ADIL income statement, ADIL cash flow statement, ADIL key metrics. See the ADIL stock overview for the latest quote and news.
ADIL balance sheet FAQ
What are Adial Pharmaceuticals's total assets?
Adial Pharmaceuticals reported total assets of $6.8 million at the end of fiscal 2025 (December 31, 2025), compared with $5.0 million a year earlier.
How much cash does Adial Pharmaceuticals have?
Adial Pharmaceuticals held $5.9 million in cash and short-term investments at the end of fiscal 2025.
What is Adial Pharmaceuticals's book value?
Adial Pharmaceuticals's shareholders' equity (book value) was $5.3 million at the end of fiscal 2025, or $7.89 per share.
What is Adial Pharmaceuticals's current ratio?
Adial Pharmaceuticals had current assets of $6.2 million and current liabilities of $1.4 million, a current ratio of 4.42 (it can cover its short-term obligations).
How much goodwill does Adial Pharmaceuticals have?
Adial Pharmaceuticals carried $0.0 million of goodwill and intangible assets, 0.0% of total assets, at the end of fiscal 2025.